Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Overview of ME/CFS

For many years, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has perplexed medical professionals and researchers. This complexity has led to the proliferation of myths surrounding the condition. Recent findings from researchers at the United States National Institute for Health (NIH) may finally provide insights into the biological underpinnings of ME/CFS.

Defining ME/CFS

ME/CFS is a multifaceted disorder that manifests differently in each individual, with extreme fatigue being the most common symptom, particularly following mental or physical exertion. Although reports of ME/CFS date back to the 1930s, the disorder was not officially recognized by the NIH until 2015. Current estimates suggest that up to 3% of the population may be affected, with underdiagnosis prevalent in marginalized communities.

Understanding the Causes of ME/CFS

The Lack of Recognition

ME/CFS remains poorly understood, contributing to its lack of recognition. This gap in knowledge has led some healthcare providers to mistakenly categorize it as a psychiatric condition, suggesting it is merely “all in their head.” Alternative theories regarding the causes of ME/CFS include infections, post-viral syndromes, immune dysfunction, stress-related chemical changes, energy production anomalies, and genetic factors. However, definitive scientific evidence linking these theories to ME/CFS is still lacking.

Treatment Options for ME/CFS

The Challenge of Treatment

Choosing an effective treatment for ME/CFS is particularly challenging due to the ambiguity surrounding the illness. Over the years, a wide range of treatment suggestions has emerged, including pharmaceuticals, psychiatric therapies, and even ice baths. Unfortunately, these interventions have often yielded inconsistent results and limited success in alleviating symptoms.

Debunking the Myth: ME/CFS is Psychogenic

One of the most damaging myths about ME/CFS is the belief that it is purely psychological. This misconception has emerged for several reasons, primarily due to past studies that failed to identify clear physical abnormalities in muscle biopsies from ME/CFS patients. Consequently, some researchers concluded that psychological factors were to blame. Additionally, early studies indicated correlations between depression, anxiety, and ME/CFS.

The Truth: Physiological Causes of Post-Exertional Malaise

Recent NIH research provides a potential physiological explanation for post-exertional malaise in ME/CFS patients. Previous hypotheses suggested that mitochondrial dysfunction might play a role. The new study found that ME/CFS patients exhibited defects in mitochondrial energy production processes. Specifically, elevated levels of the protein WASF3 hindered muscle recovery following exercise. Furthermore, emerging literature has highlighted ME/CFS as a contributing factor to depression and anxiety due to the debilitating impact of the condition on daily activities.

Exercise and ME/CFS: Myths and Realities

The Myth: Vigorous Exercise as a Treatment

The medical community has long grappled with how to treat ME/CFS without a clear understanding of its causes. The notion that vigorous exercise could “energize” patients or maintain their activity levels gained traction, primarily because initial muscle biopsies showed no significant differences between ME/CFS patients and healthy individuals. Some doctors worried that reduced physical activity could lead to muscle wasting, potentially exacerbating ME/CFS symptoms.

The Truth: Vigorous Exercise is Counterproductive

Individuals living with ME/CFS have reported that vigorous exercise often worsens their condition rather than improving it. A 2020 systematic review indicated that studies endorsing exercise as beneficial for ME/CFS lack coherence and reproducibility. Additionally, secondary analyses of these studies have frequently overlooked the adverse effects of exercise, particularly post-exertional malaise. In light of the recent NIH findings, it is clear that the rationale for using vigorous exercise as a treatment is flawed. The evidence suggests that metabolic dysfunction, rather than a lack of physical fitness, underlies the post-exertional malaise experienced by ME/CFS patients. This dysfunction implies that those with elevated WASF3 levels cannot replenish their energy stores after exertion, making vigorous exercise detrimental.

Further Reading

To gain more insights into ME/CFS and the findings from Dr. Hwang’s research team, please refer to our article, “NIH Scientists discover biological basis for ME/CFS symptoms.”

References

– Cleare A. J., et al. Chronic fatigue syndrome. BMJ Clin Evid. 2015.
– Centers for Disease Control. What Is ME/CFS?; 2023.
– Centers for Disease Control. Possible Causes. 2018.
– Calabrese L., et al. Chronic fatigue syndrome. Am Fam Physician. 1992.
– Murray JB. Psychological aspects of chronic fatigue syndrome. Percept Mot Skills. 1992.
– Wang P. Yuan, et al. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in ME/CFS. Proc Natl Acad Sci USA. 2023.
– Williams AM, et al. The psychological impact of dependency in adults with ME/CFS: A qualitative exploration. J Health Psychol. 2019.
– Larkin D., Martin C. R. The interface between chronic fatigue syndrome and depression. Neurophysiol Clin. 2017.
– Klonoff DC. Chronic Fatigue Syndrome. Clinical Infectious Diseases. 1992.
– Kim D. Y., et al. Systematic review of randomized controlled trials for ME/CFS. J. Transl Med. 2020.
– Turner-Stokes L., Wade DT. Updated NICE guidance on chronic fatigue syndrome. BMJ. 2020.
– Vink M., Vink-Niese A. Graded exercise therapy for ME/CFS is not effective and unsafe. Health Psychol Open. 2018.